Compare CSBR & SRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSBR | SRL |
|---|---|---|
| Founded | 1985 | 2017 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.0M | 83.0M |
| IPO Year | 1986 | N/A |
| Metric | CSBR | SRL |
|---|---|---|
| Price | $7.10 | $6.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 18.5K | 11.0K |
| Earning Date | 12-15-2025 | 12-26-2025 |
| Dividend Yield | N/A | ★ 16.75% |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $58,424,000.00 | $24,535,042.00 |
| Revenue This Year | $7.31 | N/A |
| Revenue Next Year | $12.01 | N/A |
| P/E Ratio | $38.57 | ★ N/A |
| Revenue Growth | ★ 9.06 | N/A |
| 52 Week Low | $5.59 | $5.13 |
| 52 Week High | $11.99 | $9.99 |
| Indicator | CSBR | SRL |
|---|---|---|
| Relative Strength Index (RSI) | 49.83 | 58.94 |
| Support Level | $6.22 | $5.85 |
| Resistance Level | $8.31 | $6.49 |
| Average True Range (ATR) | 0.42 | 0.42 |
| MACD | 0.10 | 0.04 |
| Stochastic Oscillator | 24.68 | 45.88 |
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Scully Royalty Ltd is a royalty-based company that maximizes earnings upon its iron ore royalty interest. The company's business segments include Royalty, which includes an interest in an iron ore mine; Industrial, which includes projects in resources and services; Merchant Banking, which comprises regulated merchant banking activities; and others. The majority of the revenue is generated from the Royalty segment. The company's geographical segments include Canada, Africa, America, Asia, and Europe, out of which Canada accounts for the majority of the revenue.